WHC is still in active development. Read this to understand our approach.
depiction of HCYAFALTSJYZDH-UHFFFAOYSA-N.svg
isomerdesign

Desipramine

Verificar en isomerdesign

pubchem

Desipramine

Verificar en pubchem

drugmap

Desipramine

Verificar en drugmap

wiki

Desipramine

Verificar en wiki

Data

InChI: InChI=1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3

Sinónimos: Pertrofane,BPBio1_000447, Pentofran,DESIPRAMINE [HSDB], Desimipramine,DB01151,AB00053450,NCGC00015340-05,Imipramine-M Nor,Pertofran (Salt/Mix),Desimipramine, Desipramine Hcl,NCGC00015340-22, Methylaminopropyliminodibenzyl,Desmethylimipramine;Imipramine,demethyl-;Methylaminopropyliminodibenzyl, Monodemethylimipramine,3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine,NINDS_000190,NCGC00015340-08,EN300-18293453,Spectrum4_000314,IMIPRAMINE HYDROCHLORIDE IMPURITY A [EP IMPURITY],Spectrum2_000091, (3-(10H,11H-Dibenzo[b,f]azepin-5-yl)propyl)methylamine,Desipramina [INN-Spanish],SCHEMBL34384,(3-(10H,11H-Dibenzo[b,f]azepin-5-yl)propyl)methylamine,N-desmethylimipramine,5H-Dibenzo[b, f]azepine, N-(3-methylaminopropyl)-, 10,11-Dihydro, DMI 50475,SPBio_002326, Desipraminum,NCGC00015340-09, Desmethylimipramine,Treyzafagit,5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(methylamino)propyl)-,Desipramine;Norpramin,3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methyl-1-propanamine #,EINECS 200-040-0,AKOS001681456,Desipramine [INN:BAN],CCRIS 7091, Dimethylimipramine,10,11-dihydro-5-(3-(methylamino)propyl)-5h-dibenz(b,f)azepine,5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N-methyl-,FT-0666024,TG537D343B,SPBio_000042,Spectrum_000441,Norpramine,HY-B1272A,050D475, Desimpramine,desipraminum,DESIPRAMINE [MI],Monodemethylimipramine,KBioSS_000921,5H-Dibenz[b,f]azepine, 10,11-dihydro-5-[3-(methylamino)propyl]-,Norimipramine,DESIPRAMINE [WHO-DD], Desipramina,Dezipramine,N-(3-Methylaminopropyl)iminobibenzyl,5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N-methyl-,NCGC00015340-10,UNII-TG537D343B, 10,11-Dihydro-5-(3-methylaminopropyl)-5H-dibenz(b,f)azepine, 10, 11-Dihydro-N-methyl-5H-dibez[b,f]azepine-5-propanamine,KBio2_003489,L001089,CCG-118231, Norpramine,CAS-58-28-6,NCGC00015340-07,Q423288, Dezipramine,DTXSID6022896,GTPL2399,10, 11-Dihydro-N-methyl-5H-dibez[b,f]azepine-5-propanamine,Desipraminum [INN-Latin],Demethylimipramine,3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methyl-propan-1-amine, Desipramine [INN:BAN], Pertrofane,Dimethylimipramine,Desimpramine,BRN 1432747,NCGC00015340-13,5-(3-methylaminopropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine,DESIPRAMINE [VANDF],Prestwick1_000343,10,11-Dihydro-5-(3-methylaminopropyl)-5H-dibenz(b,f)azepine,Prestwick2_000343,NCGC00015340-06,KBio2_006057,SBI-0050346.P004,3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl);-N-methylpropan-1-amine,DivK1c_000190,NCGC00015340-11,Lopac-D-3900,HMS3430H03, 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine,CS-8193,NCGC00015340-02,Imipramine, demethyl-,IDI1_000190,(3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}propyl)(methyl)amine, DMI (pharmaceutical), Desipramine (D4),D07791,KBio3_001357,BDBM35229, 5-(gamma-Methylaminopropyl)iminodibenzyl, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE,5-(gamma-Methylaminopropyl)iminodibenzyl,Desipramin, Desipramin,SDCCGSBI-0050346.P005,DMI (pharmaceutical),KBioGR_000928,STK735144,Prestwick0_000343,BSPBio_000405,NCGC00024375-04,DESIPRAMINE [INN],DMI 50475,Prestwick3_000343,4-(2H-Tetrazol-5-yl)phenylboronicacid,Desipramine (D4),[3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]methylamine, Desipramina [INN-Spanish],HSDB 3052,Lopac0_000358,3-(10,11-Dihydro-5H-dibenz[b,f]-azepin-5-yl)-N-methylpropylamine, ZERO/006017,NCGC00015340-01,CHEBI:47781,desipramine,AC-15977,C06943,ALBB-025959,3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1-amine hydrochloride,ZINC1530611,Desipramina,Desipramine,Methylaminopropyliminodibenzyl,Desipramine (INN),Pertofrane (Salt/Mix),KBio1_000190,KBio2_000921,3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Pertofrane (TN), Norpramin (TN), N-(3-Methylaminopropyl)iminobibenzyl,NCGC00015340-04, Desipraminum [INN-Latin], Sertofran,Spectrum5_000833,50-47-5, Norimipramine,(3-{2-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)(methyl)amine,Desmethylimipramine,BSPBio_002137,Sertofran,AB00053450_14, Desipramine (INN),HMS3742I19,BRD-K60762818-003-15-3,Spectrum3_000379,NCGC00015340-03,CHEMBL72

Estimated data

Solubilidad: -3.321 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 27.3% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.